BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $439 | +47.8% | 62,144 | +48.2% | 0.00% | 0.0% |
| Q2 2023 | $297 | -7.5% | 41,931 | +9.2% | 0.00% | 0.0% |
| Q1 2023 | $321 | +174.4% | 38,404 | +279.4% | 0.00% | – |
| Q4 2022 | $117 | -99.9% | 10,121 | +14.5% | 0.00% | – |
| Q3 2022 | $111,000 | +18.1% | 8,837 | 0.0% | 0.00% | – |
| Q2 2022 | $94,000 | -38.6% | 8,837 | 0.0% | 0.00% | – |
| Q1 2022 | $153,000 | +10.1% | 8,837 | -11.9% | 0.00% | – |
| Q4 2021 | $139,000 | -4.1% | 10,030 | 0.0% | 0.00% | – |
| Q3 2021 | $145,000 | -8.2% | 10,030 | 0.0% | 0.00% | – |
| Q2 2021 | $158,000 | +24.4% | 10,030 | -20.1% | 0.00% | – |
| Q1 2021 | $127,000 | +89.6% | 12,552 | +38.4% | 0.00% | – |
| Q4 2020 | $67,000 | +116.1% | 9,067 | 0.0% | 0.00% | – |
| Q3 2020 | $31,000 | -27.9% | 9,067 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +207.1% | 9,067 | +28.1% | 0.00% | – |
| Q1 2020 | $14,000 | -41.7% | 7,076 | 0.0% | 0.00% | – |
| Q4 2019 | $24,000 | -52.0% | 7,076 | -46.9% | 0.00% | – |
| Q2 2019 | $50,000 | -53.7% | 13,336 | 0.0% | 0.00% | – |
| Q1 2019 | $108,000 | +89.5% | 13,336 | +82.7% | 0.00% | – |
| Q4 2018 | $57,000 | +1.8% | 7,300 | 0.0% | 0.00% | – |
| Q3 2018 | $56,000 | +33.3% | 7,300 | 0.0% | 0.00% | – |
| Q2 2018 | $42,000 | +20.0% | 7,300 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | -2.8% | 7,300 | 0.0% | 0.00% | – |
| Q4 2017 | $36,000 | -5.3% | 7,300 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -5.0% | 7,300 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | -34.4% | 7,300 | 0.0% | 0.00% | – |
| Q1 2017 | $61,000 | +32.6% | 7,300 | 0.0% | 0.00% | – |
| Q4 2016 | $46,000 | -28.1% | 7,300 | -50.0% | 0.00% | – |
| Q3 2016 | $64,000 | +204.8% | 14,600 | +100.0% | 0.00% | – |
| Q2 2016 | $21,000 | 0.0% | 7,300 | 0.0% | 0.00% | – |
| Q1 2016 | $21,000 | -72.0% | 7,300 | 0.0% | 0.00% | – |
| Q4 2015 | $75,000 | -9.6% | 7,300 | 0.0% | 0.00% | – |
| Q3 2015 | $83,000 | -23.9% | 7,300 | 0.0% | 0.00% | – |
| Q2 2015 | $109,000 | +65.2% | 7,300 | 0.0% | 0.00% | – |
| Q1 2015 | $66,000 | -25.8% | 7,300 | 0.0% | 0.00% | – |
| Q4 2014 | $89,000 | +23.6% | 7,300 | 0.0% | 0.00% | – |
| Q3 2014 | $72,000 | – | 7,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |